Diagnostic ultrasound ( PDFDrive )

1438 PART IV Obstetric and Fetal Sonography
25. Dukler D, Oepkes D, Seaward G, et al. Noninvasive tests to predict fetal
anemia: a study comparing Doppler and ultrasound parameters. Am J Obstet
Gynecol. 2003;188(5):1310-1314.
26. Detti L, Oz U, Guney I, et al. Doppler ultrasound velocimetry for timing
the second intrauterine transfusion in fetuses with anemia from red cell
alloimmunization. Am J Obstet Gynecol. 2001;185(5):1048-1051.
27. Scheier M, Hernandez-Andrade E, Fonseca EB, Nicolaides KH. Prediction
of severe fetal anemia in red blood cell alloimmunization ater previous
intrauterine transfusions. Am J Obstet Gynecol. 2006;195(6):1550-1556.
28. Mari G, Adrignolo A, Abuhamad AZ, et al. Diagnosis of fetal anemia with
Doppler ultrasound in the pregnancy complicated by maternal blood group
immunization. Ultrasound Obstet Gynecol. 1995;5(6):400-405.
29. Dafos F, Capella-Pavlovsky M, Forestier F. Fetal blood sampling during
pregnancy with use of a needle guided by ultrasound: a study of 606 consecutive
cases. Am J Obstet Gynecol. 1985;153(6):655-660.
30. van Kamp IL, Klumper FJ, Bakkum RS, et al. he severity of immune fetal
hydrops is predictive of fetal outcome ater intrauterine treatment. Am J
Obstet Gynecol. 2001;185(3):668-673.
31. Anandakumar C, Biswas A, Wong YC, et al. Management of non-immune
hydrops: 8 years’ experience. Ultrasound Obstet Gynecol. 1996;8(3):
196-200.
32. Apkon M. Pathophysiology of hydrops fetalis. Semin Perinatol. 1995;19(6):
437-446.
33. Allan LD, Crawford DC, Sheridan R, Chapman MG. Aetiology of nonimmune
hydrops: the value of echocardiography. Br J Obstet Gynaecol.
1986;93(3):223-225.
34. van Selm M, Kanhai HH, Gravenhorst JB. Maternal hydrops syndrome: a
review. Obstet Gynecol Surv. 1991;46(12):785-788.
35. Carbillon L, Oury JF, Guerin JM, et al. Clinical biological features of Ballantyne
syndrome and the role of placental hydrops. Obstet Gynecol Surv.
1997;52(5):310-314.
36. Treadwell MC, Sherer DM, Sacks AJ, et al. Successful treatment of recurrent
non-immune hydrops secondary to fetal hyperthyroidism. Obstet Gynecol.
1996;87(5 Pt 2):838-840.
37. Makino Y, Horiuchi S, Sonoda M, et al. A case of large placental chorioangioma
with non-immunological hydrops fetalis. J Perinat Med.
1999;27(2):128-131.
38. Haak MC, Oosterhof H, Mouw RJ, et al. Pathophysiology and treatment
of fetal anemia due to placental chorioangioma. Ultrasound Obstet Gynecol.
1999;14(1):68-70.
39. Lim FY, Coleman A, Polzin W, et al. Giant chorioangiomas: perinatal
outcomes and techniques in fetoscopic devascularization. Fetal Diagn her.
2015;37(1):18-23.
40. Poeschmann RP, Verheijen RH, Van Dongen PW. Diferential diagnosis
and causes of nonimmunological hydrops fetalis: a review. Obstet Gynecol
Surv. 1991;46(4):223-231.
41. Groves AM, Fagg NL, Cook AC, Allan LD. Cardiac tumours in intrauterine
life. Arch Dis Child. 1992;67(10 Spec No):1189-1192.
42. Schmider A, Henrich W, Dahnert I, Dudenhausen JW. Prenatal therapy of
non-immunologic hydrops fetalis caused by severe aortic stenosis. Ultrasound
Obstet Gynecol. 2000;16(3):275-278.
43. Randenberg AL. Nonimmune hydrops fetalis part II: does etiology inluence
mortality? Neonatal Netw. 2010;29(6):367-380.
44. Huggon IC, Cook AC, Smeeton NC, et al. Atrioventricular septal defects
diagnosed in fetal life: associated cardiac and extra-cardiac abnormalities
and outcome. J Am Coll Cardiol. 2000;36(2):593-601.
45. Guereta LG, Burgueros M, Elorza MD, et al. Cardiac rhabdomyoma presenting
as fetal hydrops. Pediatr Cardiol. 1986;7(3):171-174.
46. Rheuban KS, McDaniel NL, Feldman PS, et al. Intrapericardial teratoma
causing nonimmune hydrops fetalis and pericardial tamponade: a case
report. Pediatr Cardiol. 1991;12(1):54-56.
47. Tollens T, Casselman F, Devlieger H, et al. Fetal cardiac tamponade due to
an intrapericardial teratoma. Ann horac Surg. 1998;66(2):559-560.
48. Geipel A, Krapp M, Germer U, et al. Perinatal diagnosis of cardiac tumors.
Ultrasound Obstet Gynecol. 2001;17(1):17-21.
49. Scurry J, Watkins A, Acton C, Drew J. Tachyarrhythmia, cardiac rhabdomyomata
and fetal hydrops in a premature infant with tuberous sclerosis.
J Paediatr Child Health. 1992;28(3):260-262.
50. Bader RS, Chitayat D, Kelly E, et al. Fetal rhabdomyoma: prenatal diagnosis,
clinical outcome, and incidence of associated tuberous sclerosis complex.
J Pediatr. 2003;143(5):620-624.
51. Paladini D, Palmieri S, Russo MG, Pacileo G. Cardiac multiple rhabdomyomatosis:
prenatal diagnosis and natural history. Ultrasound Obstet
Gynecol. 1996;7(1):84-85.
52. Perez-Aytes A, Sanchis N, Barbal A, et al. Non-immunological hydrops
fetalis and intrapericardial teratoma: case report and review. Prenat Diagn.
1995;15(9):859-863.
53. Catanzarite V, Mehalek K, Maida C, Mendoza A. Early sonographic diagnosis
of intrapericardial teratoma. Ultrasound Obstet Gynecol. 1994;4(6):
505-507.
54. Czernik C, Stiller B, Hubler M, et al. Hydrops fetalis caused by a large
intrapericardial teratoma. Ultrasound Obstet Gynecol. 2006;28(7):
973-976.
55. Benatar A, Vaughan J, Nicolini U, et al. Prenatal pericardiocentesis: its role
in the management of intrapericardial teratoma. Obstet Gynecol. 1992;79(5
Pt 2):856-859.
56. Paw PT, Jamieson SW. Surgical management of intrapericardial teratoma
diagnosed in utero. Ann horac Surg. 1997;64(2):552-554.
57. Bader R, Hornberger LK, Nijmeh LJ, et al. Fetal pericardial teratoma: presentation
of two cases and review of literature. Am J Perinatol. 2006;23(1):
53-58.
58. Simpson JM, Sharland GK. Fetal tachycardias: management and outcome
of 127 consecutive cases. Heart. 1998;79(6):576-581.
59. Eronen M. Outcome of fetuses with heart disease diagnosed in utero. Arch
Dis Child Fetal Neonatal Ed. 1997;77(1):F41-F46.
60. Naheed ZJ, Strasburger JF, Deal BJ, et al. Fetal tachycardia: mechanisms
and predictors of hydrops fetalis. J Am Coll Cardiol. 1996;27(7):
1736-1740.
61. Jaeggi ET, Carvalho JS, De Groot E, et al. Comparison of transplacental
treatment of fetal supraventricular tachyarrhythmias with digoxin, lecainide,
and sotalol: results of a nonrandomized multicenter study. Circulation.
2011;124(16):1747-1754.
62. Wacker-Gussmann A, Strasburger JF, Cuneo BF, Wakai RT. Diagnosis
and treatment of fetal arrhythmia. Am J Perinatol. 2014;31(7):617-
628.
63. Porat S, Anteby EY, Hamani Y, Yagel S. Fetal supraventricular tachycardia
diagnosed and treated at 13 weeks of gestation: a case report. Ultrasound
Obstet Gynecol. 2003;21(3):302-305.
64. Chao RC, Ho ES, Hsieh KS. Fetal atrial lutter and ibrillation: prenatal
echocardiographic detection and management. Am Heart J. 1992;124(4):
1095-1098.
65. Jaeggi ET, Hamilton RM, Silverman ED, et al. Outcome of children with
fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular
block. A single institution’s experience of 30 years. J Am Coll Cardiol.
2002;39(1):130-137.
66. McCue CM, Mantakas ME, Tingelstad JB, Ruddy S. Congenital heart block
in newborns of mothers with connective tissue disease. Circulation.
1977;56(1):82-90.
67. Litsey SE, Noonan JA, O’Connor WN, et al. Maternal connective tissue
disease and congenital heart block. Demonstration of immunoglobulin in
cardiac tissue. N Engl J Med. 1985;312(2):98-100.
68. Schmidt KG, Ulmer HE, Silverman NH, et al. Perinatal outcome of fetal
complete atrioventricular block: a multicenter experience. J Am Coll Cardiol.
1991;17(6):1360-1366.
69. Groves AM, Allan LD, Rosenthal E. Outcome of isolated congenital complete
heart block diagnosed in utero. Heart. 1996;75(2):190-194.
70. Eronen M, Siren MK, Ekblad H, et al. Short- and long-term outcome of
children with congenital complete heart block diagnosed in utero or as a
newborn. Pediatrics. 2000;106(1 Pt 1):86-91.
71. Carpenter Jr RJ, Strasburger JF, Garson Jr A, et al. Fetal ventricular pacing
for hydrops secondary to complete atrioventricular block. J Am Coll Cardiol.
1986;8(6):1434-1436.
72. Buyon JP, Hiebert R, Copel J, et al. Autoimmune-associated congenital
heart block: demographics, mortality, morbidity and recurrence rates obtained
from a national neonatal lupus registry. J Am Coll Cardiol. 1998;31(7):
1658-1666.